A Randomized Controlled Trial Examining the Effect of Topical Refrigerant Spray on the Perception of an Instantaneous Noxious Stimulus.

Purpose: Topical refrigerant spray is commonly used with routine hand injections despite mixed evidence about its efficacy in reducing the pain experience. We hypothesize that the use of topical refrigerant spray decreases the pain experience of an instantaneous noxious stimulus. Methods: Eighty adult volunteer participants were enrolled in the study. We constructed an instrument using the smooth end of a Kirschner wire mounted to the spring of a ballpoint pen to apply an instantaneous noxious stimulus to the long (middle) finger proximal nail fold. Participants completed two trials and were randomized to receive the topical refrigerant spray before either the first or second stimulus and on either the left or right side. Participants were asked to rate the pain of each experience using an 11-point Likert scale and indicate which condition they preferred, if any. Results: The mean pain ratings for the spray and no-spray conditions were 2.0 and 4.3, respectively, giving a mean difference of -2.3 (P < .001, α = 0.05). Subgroup analysis showed no significant effect of sex or medical versus nonmedical occupation (P = .28 and .11 respectively) on the mean difference in pain rating between the two conditions. Participants who received the spray first had a higher mean difference in pain rating (2.7) than that in those who received it second (1.9). Fifty-nine participants preferred the spray, whereas 21 participants either preferred no spray or had no preference (P < .0001). Conclusions: The use of topical refrigerant spray significantly decreased the perception of pain from an instantaneous noxious stimulus. A significant majority of participants also preferred the topical refrigerant spray condition. The use of topical refrigerant spray for painful procedures, such as needle insertions, may improve the overall patient experience. Type of study/level of evidence: Therapeutic I.

Autoimmunity-associated intronic SNP (rs2281808) detected by a simple phenotypic assay: Unique case or broader opportunity?

Multiple genome-wide association studies have shown that the single-nucleotide polymorphism (SNP) rs2281808 TT variant, present within the signal regulatory protein gamma (SIRPG) gene, is associated with autoimmune diseases, such as type 1 diabetes. SIRPγ is the only SIRP expressed on T cells. The role of SIRPγ in human T-cells or the effect of the TT variant are poorly understood. In this short report, we demonstrate the rather unusual finding that this intronic SNP is associated with a reduction of SIRPγ expression on T cells, both in healthy subjects as well as patients with type 1 diabetes. Using this information, we propose that a simple flow cytometric detection of SIRPγ could be a potential diagnostic testing approach for the presence of SNP in the appropriate clinical context.